Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not Hubris
25
Zitationen
2
Autoren
2018
Jahr
Abstract
In the future artificial intelligence (AI) will have the potential to improve outcomes diabetes care. With the creation of new sensors for physiological monitoring sensors and the introduction of smart insulin pens, novel data relationships based on personal phenotypic and genotypic information will lead to selections of tailored, effective therapies that will transform health care. However, decision-making processes based exclusively on quantitative metrics that ignore qualitative factors could create a quantitative fallacy. Difficult to quantify inputs into AI-based therapeutic decision-making processes include empathy, compassion, experience, and unconscious bias. Failure to consider these "softer" variables could lead to important errors. In other words, that which is not quantified about human health and behavior is still part of the calculus for determining therapeutic interventions.
Ähnliche Arbeiten
"Why Should I Trust You?"
2016 · 14.704 Zit.
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
2005 · 10.545 Zit.
A Comprehensive Survey on Graph Neural Networks
2020 · 8.931 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.532 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.046 Zit.